Company Profile

PFIZER LTD.

NSE : PFIZERBSE : 500680ISIN CODE : INE182A01018Industry : Pharmaceuticals & DrugsHouse : Pfizer - MNC
BSE4121.6533.2 (+0.81 % )
PREV CLOSE (Rs.) 4088.45
OPEN PRICE (Rs.) 4083.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 3572
TODAY'S LOW / HIGH (Rs.)4074.30 4145.00
52 WK LOW / HIGH (Rs.)2797.5 5172.95
NSE4119.60 28.1 (+0.69 % )
PREV CLOSE(Rs.) 4091.50
OPEN PRICE (Rs.) 4091.00
BID PRICE (QTY) 4119.60 (17 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 31617
TODAY'S LOW / HIGH(Rs.) 4070.00 4149.00
52 WK LOW / HIGH (Rs.)2792.25 5170

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 8.01
TTM EPS (Rs.) 111.29
P/E Ratio 37.03
Book Value (Rs.) 742.22
Face Value (Rs.) 10
MCap (Rs. in Mn) 188556.14
Price/Earning (TTM) 30.79
Price/Sales (TTM) 8.76
Price/Book (MRQ) 5.55
PAT Margin (%) 20.61
ROCE (%) 23.22
Incorporation Year : 1950

Management Info :

R A Shah - Chairman S Sridhar - Managing Director

Registered Office :

Address : The Capital, 1802/1901,Plot No.c-70, G Block,Bandra Kurla Complex, Bandra (East),
Mumbai,
Maharashtra-400051

Phone : 91 22 6693 2000

Registrar's Details : K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS More
18Mar03-18-2020$Pfizer informs about loss of share certificate Pfizer informs about loss of

Pfizer has informed about loss of share certificate/ issue of duplicate share certificate, pursuant to Regulation 39(3) of SEBI (Listing obligations and disclosure requirement) Regulations 2015..

The above information is a part of company’s filings submitted to BSE.




Pfizer has informed about loss of share certificate/ issue of d..
03Mar03-03-2020$Pfizer’s parent company identifies some antiviral compounds to inhibit coronavirus: Report Pfizer’s parent company id

Pfizer’s parent company in the US has reportedly found some antiviral compounds that have the potential to inhibit coronavirus. The company is engaging with a third party to screen the compounds and it hopes that they would get the results from screening by the end of March. If any of the compounds are successful the company would start testing them by the end of the year.

Pfizer has produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections.

Pfizer’s parent company in the US has reportedly found some a..
03Mar03-03-2020$Pfizer soars on the buzz of its parent company identifies some antiviral compounds to inhibit coronavirus Pfizer soars on the buzz of

Pfizer is currently trading at Rs. 4416.75, up by 157.90 points or 3.71% from its previous closing of Rs. 4258.85 on the BSE.

The scrip opened at Rs. 4274.95 and has touched a high and low of Rs. 4929.85 and Rs. 4271.15 respectively. So far 36100 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 4,929.85 on 03-Mar-2020 and a 52 week low of Rs. 2797.50 on 23-Aug-2019.

Last one week high and low of the scrip stood at Rs. 4929.85 and Rs. 4054.85 respectively. The current market cap of the company is Rs. 20213.41 crore.

The promoters holding in the company stood at 63.92%, while Institutions and Non-Institutions held 16.72% and 19.36% respectively.

Pfizer’s parent company in the US has reportedly found some antiviral compounds that have the potential to inhibit coronavirus. The company is engaging with a third party to screen the compounds and it hopes that they would get the results from screening by the end of March. If any of the compounds are successful the company would start testing them by the end of the year.

Pfizer has produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections.

Pfizer is currently trading at Rs. 4416.75, up by 157.90 points..
14Feb02-14-2020$Pfizer informs about issuance of duplicate share certificates Pfizer informs about issuanc

Pfizer has informed that pursuant to Regulation 39(3) and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Registrar and Transfer Agent of the Company, Kfin Technologies has received requests for issue of duplicate Share Certificates from the Shareholders, Salim Majeed Patel and Arati Roy.

The above information is a part of company’s filings submitted to BSE.

Pfizer has informed that pursuant to Regulation 39(3) and other..
14Feb02-14-2020$Pfizer informs about un-audited financial results Pfizer informs about un-audi

Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Pfizer has  informed that the company has submitted the un-audited financial results for the quarter ended December 31, 2019, which were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 12:00 noon and concluded at 2:00 pm. Also the company has enclosed the Limited Review Report by its Auditors Walker Chandiok & Co LLP, in respect of the results.

The above information is a part of company’s filings submitted to BSE.

Pursuant to Regulation 33 of the SEBI (Listing Obligations and..
Financials More
Rs. in Millions
QTR Mar 20 ANNUAL 20
Net Profit1030.15091.3
Gross Profit 1219 6424.9
Operating Profit 1539.37565.8
Net Sales 5020.121516.5
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Sanofi India (BSE)
 7594.15 (1.05%)
M.Cap ( in Cr)
17489.80
IOL Chem & Pharma (BSE)
 623.65 (7.19%)
M.Cap ( in Cr)
3661.17
Shilpa Medicare (BSE)
 516.80 (5.92%)
M.Cap ( in Cr)
4213.31
Hester Biosciences (BSE)
 1238.35 (1.93%)
M.Cap ( in Cr)
1053.45
Aarti Drugs (BSE)
 1383.45 (1.66%)
M.Cap ( in Cr)
3223.44
Shareholding Pattern More
MUTUAL FUNDS/UTI 9.34 %
PROMOTERS 63.92 %
FI/BANKS/INSURANCE 3.03 %
NON-INSTITUTION 19.73 %
FII 0 %
GOVERNMENT 0 %
F & O Quotes